Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the symptomatic relief of diarrhea predominant irritable bowel syndrome (IBS-D). METHODS: A total of 20 patients wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society of Neurogastroenterology and Motility 2012
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://ncbi.nlm.nih.gov/pubmed/22837880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2012.18.3.317
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak